17-beta-hydroxysteroid dehydrogenase deficiency: Difference between revisions
Line 42: | Line 42: | ||
==Treatment== | ==Treatment== | ||
[[17-beta-hydroxysteroid dehydrogenase deficiency medical therapy|Medical Therapy | [[17-beta-hydroxysteroid dehydrogenase deficiency medical therapy|Medical Therapy]] | [[17-beta-hydroxysteroid dehydrogenase deficiency primary prevention|Primary Prevention]] | [[17-beta-hydroxysteroid dehydrogenase deficiency secondary prevention|Secondary Prevention]] | [[17-beta-hydroxysteroid dehydrogenase deficiency cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[17-beta-hydroxysteroid dehydrogenase deficiency future or investigational therapies|Future or Investigational Therapies]] | ||
==Case Studies== | ==Case Studies== |
Revision as of 15:16, 19 September 2012
17-beta-hydroxysteroid dehydrogenase deficiency | |
OMIM | 264300 |
---|---|
DiseasesDB | 32638 |
For patient information, click here
17-beta-hydroxysteroid dehydrogenase deficiency Microchapters |
Differentiating 17-beta-hydroxysteroid dehydrogenase deficiency from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
17-beta-hydroxysteroid dehydrogenase deficiency On the Web |
American Roentgen Ray Society Images of 17-beta-hydroxysteroid dehydrogenase deficiency |
Directions to Hospitals Treating 17-beta-hydroxysteroid dehydrogenase deficiency |
Risk calculators and risk factors for 17-beta-hydroxysteroid dehydrogenase deficiency |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating 17-beta-hydroxysteroid dehydrogenase deficiency from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Molecular Genetic Studies | Genotyping | Pelvic X Ray | CT | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies